| Name | HBV-IN-13 |
|---|
| Description | HBV-IN-12 is a potent hepatitis B surface antigen (HBsAg) inhibitor. From patent WO2021204252A1, compound 1_B[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Tetracyclic compound as hepatitis b surface antigen inhibitor. WO2021204252A1. |
| Molecular Formula | C22H25NO7 |
|---|---|
| Molecular Weight | 415.44 |